Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 30.48

-0.6%

2:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (505)	10/21/2010 10:15:14 PM
From: mcbio	Read Replies (1) of 566

No prob, I'm a former RIGL long and back to following the stock closely again as I think it's an interesting company. I could go long again at some point. But, I will say I have some concerns about AZN's Phase 3 trial design of testing FosD only against MTX and anti-TNF failures. Isn't this the exact same study design where FosD flopped in the Phase 2 TASKi3 trial?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next